Hims & Hers Health Inc. ($HIMS) Stock Forecast: Down 5.4% Today

What is Hims & Hers Health Inc.?

HIMS is a company operating in the personalized healthcare industry, known for its subscription-based model and online revenues. Today, the stock experienced a significant bearish movement in the market.

Why is Hims & Hers Health Inc. going down?

HIMS stock is down 5.4% on Jun 13, 2025 14:51

• Despite strong subscriber growth and online revenues, HIMS stock saw a notable decline, possibly due to profit-taking by investors after a period of gains.
• Unusual options activity indicating a bullish stance by investors might not have translated into immediate positive price action, leading to a disconnect between market sentiment and actual stock performance.
• The overall market rise could have contributed to a sector rotation, with investors moving away from HIMS stock temporarily in favor of other opportunities.
• The surge in Bruker stock following an acquisition news might have diverted attention and investment away from HIMS, impacting its stock price negatively.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

HIMS' Subscriptions Power Personalized Care & Recurring Revenue Growth

Hims & Hers' 38.4% subscriber growth and $576.4 million online revenues highlight the power of its personalized subscription model.

https://www.zacks.com/stock/news/2496368/hims-subscriptions-power-personalized-care-recurring-revenue-growth

Hims & Hers Health, Inc. ( HIMS ) Stock Slides as Market Rises: Facts to Know Before You Trade

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $55.25, denoting a -2.83% change from the preceding trading day.

https://www.zacks.com/stock/news/2493275/hims-hers-health-inc-hims-stock-slides-as-market-rises-facts-to-know-before-you-trade

Bruker Stock Set to Gain From Acquisition of Austria's biocrates

BRKR strengthens its MS-based metabolomics platform with the biocrates deal, boosting investor sentiment.

https://www.zacks.com/stock/news/2492104/bruker-stock-set-to-gain-from-acquisition-of-austrias-biocrates

Why Hims & Hers Health ( HIMS ) Might be Well Poised for a Surge

Hims & Hers Health (HIMS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

https://www.zacks.com/stock/news/2491134/why-hims-hers-health-hims-might-be-well-poised-for-a-surge

Hims & Hers Health Unusual Options Activity - Hims & Hers Health ( NYSE:HIMS )

Whales with a lot of money to spend have taken a noticeably bullish stance on Hims & Hers Health. Looking at options history for Hims & Hers Health HIMS we detected 12 trades. If we consider the specifics of each trade, it is accurate to state that 58% of the investors opened trades with bullish ...

https://www.benzinga.com/insights/options/25/06/45837544/hims-hers-health-unusual-options-activity

Trending Today

Jito ($JTO) Crypto Forecast: Up 17.6% Today

Solana ($SOL) Crypto Forecast: Up 6.8% Today

Hims & Hers Health Inc. Price History

11.05.2025 - HIMS Stock was up 5.1%

• The stock of Hims & Hers Health, Inc. (HIMS) experienced a bullish movement due to:
• Positive investor sentiment driven by the company's recent acquisitions, such as the ZAVA acquisition for European growth and digital health innovation.
• Solid earnings estimate revisions indicating a potential surge in the near term.
• Unusual options activity showing a bullish stance from investors with significant capital, further boosting confidence in the stock.
• The acquisition of Austria's biocrates by Bruker (BRKR) may have indirectly contributed to the positive market sentiment, as it strengthened BRKR's metabolomics platform, potentially signaling growth opportunities in the sector.

04.05.2025 - HIMS Stock was down 5.9%

• Despite positive sentiment from market whales and expectations of accretive deals, HIMS stock experienced a bearish trend today.
• The bullish bets on HIMS options by investors did not translate into a positive market movement, indicating a disconnect between expectations and actual performance.
• The discrepancy between bullish stances and the bearish movement could be attributed to broader market volatility or specific company-related factors not captured in recent updates.
• Investors should closely monitor future developments and market trends to make informed decisions regarding HIMS stock.

06.05.2025 - HIMS Stock was up 5.6%

• HIMS stock saw significant positive movement today.
• The recent acquisition of ZAVA is supporting the company's international expansion and digital health innovation, boosting market sentiment.
• Analysts are optimistic about the company's growth prospects, with the ZAVA acquisition poised to target a substantial market opportunity in Europe.
• Following some initial declines in stock price after the acquisition announcement, investors are now acknowledging the future value and growth possibilities of Hims & Hers Health, prompting a rise in the stock price.

28.04.2025 - HIMS Stock was down 6.2%

• The bearish movement in HIMS stock could be attributed to the noticeable bearish stance taken by whales with significant capital in options trading for Hims & Hers Health.
• The FDA announcement regarding the removal of semaglutide from the drug shortage list and the impending end of the grace period for compounded versions of semaglutide products might have impacted investor confidence in HIMS, leading to the stock tumbling.
• Investors may have reacted negatively to the uncertainty surrounding the future sales and production of semaglutide products, contributing to the bearish trend in HIMS stock today.

13.05.2025 - HIMS Stock was down 5.4%

• Despite strong subscriber growth and online revenues, HIMS stock saw a notable decline, possibly due to profit-taking by investors after a period of gains.
• Unusual options activity indicating a bullish stance by investors might not have translated into immediate positive price action, leading to a disconnect between market sentiment and actual stock performance.
• The overall market rise could have contributed to a sector rotation, with investors moving away from HIMS stock temporarily in favor of other opportunities.
• The surge in Bruker stock following an acquisition news might have diverted attention and investment away from HIMS, impacting its stock price negatively.

21.04.2025 - HIMS Stock was down 5.7%

• HIMS stock decreased by 3.1% over the past three months, reflecting a strong bearish trend.
• A comparison with DBV Technologies S.A. (DBVT) suggests that HIMS might be trailing in performance relative to its peers in the industry.
• Despite HIMS' efforts to diversify its product line and utilize AI, external factors are affecting its performance negatively.
• The decline in stock value may be due to concerns among investors regarding HIMS' ability to address these external challenges effectively and stay competitive in the market.

30.04.2025 - HIMS Stock was up 6.8%

• HIMS stock saw significant growth despite the introduction of a new obesity care option priced at $549/month.
• Some investors took a bearish stance in options trading, causing initial concerns, but overall market sentiment towards HIMS remained positive.
• Comparisons with Amwell in the telehealth sector possibly influenced the stock's upward movement, highlighting HIMS as a promising player in healthcare.

30.04.2025 - HIMS Stock was up 6.1%

• Despite launching a new affordable obesity care program, the stock of HIMS experienced a bullish movement.
• The bearish stance taken by some investors in options trading did not seem to impact the overall market sentiment towards HIMS.
• The positive market movement could be attributed to the potential growth prospects of the company's holistic weight loss solutions.
• Investors may be optimistic about the company's ability to tap into the expanding telehealth market, driving the bullish movement in the stock.

22.04.2025 - HIMS Stock was down 9.3%

• The FDA's announcement on semaglutide's removal from the drug shortage list and the end of the grace period for compounded versions possibly had a negative impact on HIMS, leading to the bearish movement.
• Despite HIMS' efforts in improving its offerings and utilizing AI technology, it appears that broader market challenges have overshadowed these initiatives, causing the stock to decline.
• A comparison with DBV Technologies and overall sector performance suggests that HIMS might be encountering specific challenges or market conditions affecting its stock negatively.
• Investors might be wary of the implications of these events on HIMS' future performance, contributing to the observed bearish trend.

05.05.2025 - HIMS Stock was down 7.8%

• The recent acquisition deal with ZAVA aimed at expanding into Germany, France, and Ireland was viewed positively to strengthen its global presence.
• Despite the favorable acquisition news, the stock witnessed a downward trend, potentially influenced by investors taking profits after previously holding bullish views on HIMS options.
• The market's negative reaction to the stock, despite anticipated accretion by 2026, suggests investor uncertainty regarding the company's future prospects.
• The discrepancy between the positive expansion news and the market's downward movement may be linked to broader market fluctuations and investor sentiment surrounding the stock.

03.05.2025 - HIMS Stock was up 12.0%

• HIMS stock saw a significant bullish movement today.
• Positive expectations of a deal becoming accretive by 2026 are believed to have driven this bullish sentiment.
• Whales in the market have taken a noticeably bullish stance, potentially contributing to the upward momentum.
• The launch of a new obesity care solution, Wegovy, did not deter the stock's bullish trend, demonstrating resilience amid short-term fluctuations.

03.05.2025 - HIMS Stock was down 16.0%

• Despite recent bullish bets by market whales on HIMS options, the stock experienced a significant bearish movement today.
• The expectation of the deal to be accretive by 2026 did not seem to have an immediate positive impact on the stock price.
• The comparison with Amwell in the telehealth sector may have influenced investor sentiment, leading to the bearish market movement for HIMS today.
• The conflicting signals from the bullish bets by whales and the actual market performance suggest a complex market sentiment towards Hims & Hers Health.